Reply to A. Avan et al Journal Article
| Authors: | Baselga, J.; Clark, E.; Kiermaier, A.; Swain, S. M. |
| Article Title: | Reply to A. Avan et al |
| Keywords: | gene mutation; patient selection; letter; biological marker; breast cancer; epidermal growth factor receptor 2; cancer tissue; trastuzumab; pertuzumab; phase 3 clinical trial (topic); cancer prognosis; human; priority journal; her2 positive metastatic breast cancer |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Start Page: | 1712 |
| Language: | English |
| DOI: | 10.1200/jco.2015.60.8398 |
| PROVIDER: | scopus |
| PUBMED: | 25870094 |
| DOI/URL: | |
| Notes: | Export Date: 3 August 2015 -- Source: Scopus |
